drugset / Trial / NCT00904059
Drug-Drug Interaction Study in Healthy Subjects
RandomizedCrossoverOpen-label
Summary
The purpose of this study is to assess the pharmacokinetics and safety of BMS-790052 and BMS-650032 when co-administered and when administered alone
Timeline
- Start
- 2009-05
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Asunaprevir | Small molecule | 200 mg | Oral |
| Subject | Asunaprevir | Small molecule | 600 mg | Oral |
| Subject | Daclatasvir | Small molecule | 30 mg | Oral |
| Subject | Daclatasvir | Small molecule | 60 mg | Oral |